Li, L., Zhao, L., Zhou, D., Yu, Y., Zhang, P., Zheng, J., Lin, Z., Yu, D., Ren, J., Zhang, J., Zhou, P., Zhang, D., Zhang, T.

Background
Despite advancements in treatment modalities, several patients with colorectal cancer (CRC) remain unresponsive to immune checkpoint inhibitor therapy. Pyroptosis, an inflammatory programmed cell death process, holds substantial promise for…